4
Changes in Ownership
PULSE BIOSCIENCES, INC. Filed Acc 0001437749-25-029646
Chief Commercial Officer sold 20,400 shares at an average $18.49 ($377,192)
- Chief Commercial Officer acquired 20,400 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Danahy Kevin Patrick · Chief Commercial Officer
Table I: Non-derivative
4 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2025-09-18 | Exercise or conversion : show line 1 in the form 10b5-1 | +20,000 | $1.53 | $30,600 | 63,298 | D |
| 2025-09-18 | Sale : show line 2 in the form 10b5-1 | −20,000 | $18.49 | $369,800 | 43,298 | D |
| 2025-09-19 | Exercise or conversion : show line 3 in the form 10b5-1 | +400 | $1.53 | $612 | 43,698 | D |
| 2025-09-19 | Sale : show line 4 in the form 10b5-1 | −400 | $18.48 | $7,392 | 43,298 | D |
| Open-market sales · 20,400 sh · avg $18.49 · $377,192 | ||||||
Table II: Derivative
2 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2025-09-18 | Exercise or conversion : show line 5 in the form 10b5-1 Stock Option (right to buy) | −20,000 | 430,000 | D |
| 2025-09-19 | Exercise or conversion : show line 6 in the form 10b5-1 Stock Option (right to buy) | −400 | 429,600 | D |
Loading xslF345X05/rdgdoc.xml…